What is the current annual EBITDA of IQV?

As of today, IQV annual EBITDA is $3.43B

What is 1-year change in IQV annual EBITDA?

IQV annual EBITDA is up +1.42% year-over-year

What is 3-year change in IQV annual EBITDA?

IQV annual EBITDA is up +15.64% over the past 3 years

How far is IQV annual EBITDA from its all-time high?

IQV annual EBITDA is currently at its all-time high

How does IQV annual EBITDA rank versus sector peers?

IQV annual EBITDA is higher than 96.81% of companies in Healthcare sector

When is IQV next annual earnings release?

The next annual earnings release for IQV is on February 11, 2027

What is the current quarterly EBITDA of IQV?

As of today, IQV quarterly EBITDA is $928.00M

What is IQV quarterly EBITDA most recent change?

IQV quarterly EBITDA was up +7.53% on September 30, 2026

What is 1-year change in IQV quarterly EBITDA?

IQV quarterly EBITDA is up +8.16% year-over-year

How far is IQV quarterly EBITDA from its all-time high?

IQV quarterly EBITDA is currently -3.63% below its historical high of $963.00M set on December 31, 2025

How does IQV quarterly EBITDA rank versus sector peers?

IQV quarterly EBITDA is higher than 96.45% of companies in Healthcare sector

When is IQV next earnings release?

The next earnings release for IQV is on February 11, 2027

What is the current TTM EBITDA of IQV?

As of today, IQV TTM EBITDA is $3.62B

What is IQV TTM EBITDA most recent change?

IQV TTM EBITDA was up +1.97% on September 30, 2026

What is 1-year change in IQV TTM EBITDA?

IQV TTM EBITDA is up +6.73% year-over-year

How far is IQV TTM EBITDA from its all-time high?

IQV TTM EBITDA is currently at its all-time high

How does IQV TTM EBITDA rank versus sector peers?

IQV TTM EBITDA is higher than 96.45% of companies in Healthcare sector

When is IQV next earnings release?

The next earnings release for IQV is on February 11, 2027

IQV EBITDA History & Chart Since 2010

Annual EBITDA

$3.43B$48.00M+1.42%

December 31, 2025

Summary

Current Value: As of today, IQV annual EBITDA is $3.43B, up +1.42% on December 31, 2025
Historical Performance: IQV annual EBITDA is up +15.64% over the past 3 years, up +65.83% over the past 5 years
All-Time High Comparison: IQV annual EBITDA is currently at its all-time high
3-Year Low Comparison: IQV annual EBITDA is +15.64% above its 3-year low of $2.97B reached on an earlier date
Sector Comparison: IQV annual EBITDA is higher than 96.81% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

IQV Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$3.43B	+1.4%	+15.6%	+65.8%	+579.4%
Quarterly EBITDA	Sep 30, 26	$928.00M	+8.2%	+14.2%	+45.2%	–
TTM EBITDA	Sep 30, 26	$3.62B	+6.7%	+17.0%	+40.8%	–
Price	Oct 30, 26	$267.33	+23.5%	+50.9%	+2.3%	–
PE Ratio	Oct 30, 26	32.48	+9.3%	+9.3%	-51.1%	–
Annual Revenue	Dec 31, 25	$16.30B	+5.8%	+13.1%	+43.5%	+315.5%
Annual EPS	Dec 31, 25	$7.84	+4.7%	+36.9%	+447.9%	+529.2%
	Dec 31, 25	$2.29B	+0.8%	+24.5%	+192.5%	+443.5%
Annual Net Income	Dec 31, 25	$1.36B	-0.9%	+24.8%	+341.9%	+723.6%

EBITDA Highs

IQV Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$3.43B	Dec 31, 25	at high
5Y	$3.43B	Dec 31, 25	at high
All	$3.43B	Dec 31, 25	at high

EBITDA Lows

IQV Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$2.97B	N/A	+15.6%
5Y	$2.07B	N/A	+65.8%
All	$473.57M	Dec 31, 11	+624.5%

EBITDA History

Year	Value	Change
2025	$3.43B	+1.4%
2024	$3.38B	+6.9%
2023	$3.17B	+6.7%
2022	$2.97B	+10.6%
2021	$2.68B	+29.6%
2020	$2.07B	+0.5%
2019	$2.06B	+5.5%
2018	$1.95B	+9.2%

Year	Value	Change
2017	$1.79B	+57.2%
2016	$1.14B	+39.6%
2015	$813.53M	+13.5%
2014	$716.60M	+19.7%
2013	$598.51M	+16.5%
2012	$513.61M	+8.5%
2011	$473.57M	-6.2%
2010	$504.99M	-

FAQ

What is the current annual EBITDA of IQV?: As of today, IQV annual EBITDA is $3.43B
What is 1-year change in IQV annual EBITDA?: IQV annual EBITDA is up +1.42% year-over-year
What is 3-year change in IQV annual EBITDA?: IQV annual EBITDA is up +15.64% over the past 3 years
How far is IQV annual EBITDA from its all-time high?: IQV annual EBITDA is currently at its all-time high
How does IQV annual EBITDA rank versus sector peers?: IQV annual EBITDA is higher than 96.81% of companies in Healthcare sector
When is IQV next annual earnings release?: The next annual earnings release for IQV is on February 11, 2027

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$928.00M$65.00M+7.53%

September 30, 2026

Summary

Current Value: As of today, IQV quarterly EBITDA is $928.00M, up +7.53% on September 30, 2026
Historical Performance: IQV quarterly EBITDA is up +8.16% year-over-year, up +14.15% over the past 3 years
All-Time High Comparison: IQV quarterly EBITDA is currently -3.63% below its historical high of $963.00M set on December 31, 2025
3-Year Low Comparison: IQV quarterly EBITDA is +17.77% above its 3-year low of $788.00M reached on March 31, 2024
Sector Comparison: IQV quarterly EBITDA is higher than 96.45% of companies in Healthcare sector

Performance

IQV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$928.00M	+7.5%	+8.2%	+14.2%	+45.2%
Annual EBITDA	Dec 31, 25	$3.43B	–	+1.4%	+15.6%	+65.8%
TTM EBITDA	Sep 30, 26	$3.62B	+2.0%	+6.7%	+17.0%	+40.8%
Price	Oct 30, 26	$267.33	+12.4%	+23.5%	+50.9%	+2.3%
PE Ratio	Oct 30, 26	32.48	+10.1%	+9.3%	+9.3%	-51.1%
Quarterly Revenue	Sep 30, 26	$4.43B	+1.3%	+8.0%	+18.3%	+30.6%
Quarterly EPS	Sep 30, 26	$2.10	+37.0%	+8.7%	+28.3%	+56.8%
	Sep 30, 26	$607.00M	+6.3%	+6.1%	+17.6%	+100.3%
Quarterly Net Income	Sep 30, 26	$352.00M	+36.4%	+6.0%	+16.2%	+34.9%

Quarterly EBITDA Highs

IQV Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$963.00M	Dec 31, 25	-3.6%
3Y	$963.00M	Dec 31, 25	-3.6%
5Y	$963.00M	Dec 31, 25	-3.6%
All	$963.00M	Dec 31, 25	-3.6%

Quarterly EBITDA Lows

IQV Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$858.00M	N/A	+8.2%
3Y	$788.00M	Mar 31, 24	+17.8%
5Y	$639.00M	N/A	+45.2%
All	$118.10M	Mar 31, 12	+685.8%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$928.00M	+7.5%
Jun 2026	$863.00M	+0.2%
Mar 2026	$861.00M	-10.6%
Dec 2025	$963.00M	+12.2%
Sep 2025	$858.00M	+5.7%
Jun 2025	$812.00M	+2.5%
Mar 2025	$792.00M	-14.4%
Dec 2024	$925.00M	+8.4%
Sep 2024	$853.00M	+4.4%
Jun 2024	$817.00M	+3.7%
Mar 2024	$788.00M	-5.4%
Dec 2023	$833.00M	+2.5%
Sep 2023	$813.00M	+2.3%
Jun 2023	$795.00M	+9.8%
Mar 2023	$724.00M	-4.4%
Dec 2022	$757.00M	+5.7%
Sep 2022	$716.00M	-3.0%
Jun 2022	$738.00M	-2.6%
Mar 2022	$758.00M	+3.8%
Dec 2021	$730.00M	+14.2%
Sep 2021	$639.00M	+1.3%
Jun 2021	$631.00M	-6.1%
Mar 2021	$672.00M	+7.5%
Dec 2020	$625.00M	+17.9%
Sep 2020	$530.00M	+36.2%
Jun 2020	$389.00M	-25.9%
Mar 2020	$525.00M	+2.5%
Dec 2019	$512.00M	-2.3%
Sep 2019	$524.00M	+3.8%
Jun 2019	$505.00M	-2.5%

Month	Value	Change
Mar 2019	$518.00M	+2.4%
Dec 2018	$506.00M	+3.7%
Sep 2018	$488.00M	+4.3%
Jun 2018	$468.00M	-4.3%
Mar 2018	$489.00M	+8.4%
Dec 2017	$451.00M	-2.0%
Sep 2017	$460.00M	+8.5%
Jun 2017	$424.00M	-7.4%
Mar 2017	$458.00M	-5.4%
Dec 2016	$483.89M	+101.9%
Sep 2016	$239.65M	+13.3%
Jun 2016	$211.49M	-2.5%
Mar 2016	$216.91M	-2.6%
Dec 2015	$222.79M	+4.7%
Sep 2015	$212.75M	+8.2%
Jun 2015	$196.64M	+8.4%
Mar 2015	$181.35M	-8.0%
Dec 2014	$197.06M	+9.2%
Sep 2014	$180.50M	+6.5%
Jun 2014	$169.54M	+0.0%
Mar 2014	$169.50M	-2.0%
Dec 2013	$172.90M	+8.1%
Sep 2013	$159.91M	+29.9%
Jun 2013	$123.08M	-13.1%
Mar 2013	$141.66M	+19.0%
Dec 2012	$119.04M	-9.7%
Sep 2012	$131.86M	+0.6%
Jun 2012	$131.09M	+11.0%
Mar 2012	$118.10M	-

FAQ

What is the current quarterly EBITDA of IQV?: As of today, IQV quarterly EBITDA is $928.00M
What is IQV quarterly EBITDA most recent change?: IQV quarterly EBITDA was up +7.53% on September 30, 2026
What is 1-year change in IQV quarterly EBITDA?: IQV quarterly EBITDA is up +8.16% year-over-year
How far is IQV quarterly EBITDA from its all-time high?: IQV quarterly EBITDA is currently -3.63% below its historical high of $963.00M set on December 31, 2025
How does IQV quarterly EBITDA rank versus sector peers?: IQV quarterly EBITDA is higher than 96.45% of companies in Healthcare sector
When is IQV next earnings release?: The next earnings release for IQV is on February 11, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$3.62B$70.00M+1.97%

September 30, 2026

Summary

Current Value: As of today, IQV TTM EBITDA is $3.62B, up +1.97% on September 30, 2026
Historical Performance: IQV TTM EBITDA is up +6.73% year-over-year, up +17.03% over the past 3 years
All-Time High Comparison: IQV TTM EBITDA is currently at its all-time high
3-Year Low Comparison: IQV TTM EBITDA is +17.03% above its 3-year low of $3.09B reached on an earlier date
Sector Comparison: IQV TTM EBITDA is higher than 96.45% of companies in Healthcare sector

Performance

IQV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$3.62B	+2.0%	+6.7%	+17.0%	+40.8%
Annual EBITDA	Dec 31, 25	$3.43B	–	+1.4%	+15.6%	+65.8%
Quarterly EBITDA	Sep 30, 26	$928.00M	+7.5%	+8.2%	+14.2%	+45.2%
Price	Oct 30, 26	$267.33	+12.4%	+23.5%	+50.9%	+2.3%
PE Ratio	Oct 30, 26	32.48	+10.1%	+9.3%	+9.3%	-51.1%
TTM Revenue	Sep 30, 26	$17.32B	+1.9%	+8.9%	+16.6%	+28.1%
TTM EPS	Sep 30, 26	$8.23	+2.1%	+13.0%	+38.1%	+109.3%
	Sep 30, 26	$2.40B	+1.5%	+6.2%	+24.6%	+96.3%
TTM Net Income	Sep 30, 26	$1.40B	+1.4%	+9.0%	+25.4%	+78.7%

TTM EBITDA Highs

IQV TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$3.62B	Sep 30, 26	at high
3Y	$3.62B	Sep 30, 26	at high
5Y	$3.62B	Sep 30, 26	at high
All	$3.62B	Sep 30, 26	at high

TTM EBITDA Lows

IQV TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$3.39B	N/A	+6.7%
3Y	$3.09B	N/A	+17.0%
5Y	$2.57B	N/A	+40.8%
All	$118.10M	Mar 31, 12	+2960.9%

TTM EBITDA History

Month	Value	Change
Sep 2026	$3.62B	+2.0%
Jun 2026	$3.55B	+1.5%
Mar 2026	$3.49B	+2.0%
Dec 2025	$3.43B	+1.1%
Sep 2025	$3.39B	+0.1%
Jun 2025	$3.38B	-0.1%
Mar 2025	$3.39B	+0.1%
Dec 2024	$3.38B	+2.8%
Sep 2024	$3.29B	+1.2%
Jun 2024	$3.25B	+0.7%
Mar 2024	$3.23B	+2.0%
Dec 2023	$3.17B	+2.5%
Sep 2023	$3.09B	+3.2%
Jun 2023	$2.99B	+1.9%
Mar 2023	$2.94B	-1.1%
Dec 2022	$2.97B	+0.9%
Sep 2022	$2.94B	+2.7%
Jun 2022	$2.87B	+3.9%
Mar 2022	$2.76B	+3.2%
Dec 2021	$2.67B	+4.1%
Sep 2021	$2.57B	+4.4%
Jun 2021	$2.46B	+10.9%
Mar 2021	$2.22B	+7.1%
Dec 2020	$2.07B	+5.8%
Sep 2020	$1.96B	+0.3%
Jun 2020	$1.95B	-5.6%
Mar 2020	$2.07B	+0.3%
Dec 2019	$2.06B	+0.3%
Sep 2019	$2.05B	+1.8%
Jun 2019	$2.02B	+1.9%

Month	Value	Change
Mar 2019	$1.98B	+1.5%
Dec 2018	$1.95B	+2.9%
Sep 2018	$1.90B	+1.5%
Jun 2018	$1.87B	+2.4%
Mar 2018	$1.82B	+1.7%
Dec 2017	$1.79B	-1.8%
Sep 2017	$1.83B	+13.7%
Jun 2017	$1.61B	+15.3%
Mar 2017	$1.39B	+20.9%
Dec 2016	$1.15B	+29.3%
Sep 2016	$890.84M	+3.1%
Jun 2016	$863.94M	+1.7%
Mar 2016	$849.08M	+4.4%
Dec 2015	$813.53M	+3.3%
Sep 2015	$787.80M	+4.3%
Jun 2015	$755.55M	+3.7%
Mar 2015	$728.45M	+1.7%
Dec 2014	$716.60M	+3.5%
Sep 2014	$692.43M	+3.1%
Jun 2014	$671.84M	+7.4%
Mar 2014	$625.39M	+4.7%
Dec 2013	$597.55M	+9.9%
Sep 2013	$543.69M	+5.4%
Jun 2013	$515.65M	-1.5%
Mar 2013	$523.65M	+4.7%
Dec 2012	$500.09M	+31.2%
Sep 2012	$381.05M	+52.9%
Jun 2012	$249.19M	+111.0%
Mar 2012	$118.10M	-

FAQ

What is the current TTM EBITDA of IQV?: As of today, IQV TTM EBITDA is $3.62B
What is IQV TTM EBITDA most recent change?: IQV TTM EBITDA was up +1.97% on September 30, 2026
What is 1-year change in IQV TTM EBITDA?: IQV TTM EBITDA is up +6.73% year-over-year
How far is IQV TTM EBITDA from its all-time high?: IQV TTM EBITDA is currently at its all-time high
How does IQV TTM EBITDA rank versus sector peers?: IQV TTM EBITDA is higher than 96.45% of companies in Healthcare sector
When is IQV next earnings release?: The next earnings release for IQV is on February 11, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

IQV Official Website www.iqvia.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1478242/000119312525312900/0001193125-25-312900-index.htm
IQV Profile on Yahoo Finance finance.yahoo.com/quote/IQV
IQV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iqv